Equicapita Announces Deal Partner for Shaw Group of Dental Laboratories
TORONTO, ONTARIO (January 14, 2019) – Equicapita Income Trust and Equicapita Investment Corp. (collectively, “Equicapita”) are pleased to announce that Ali Rezaei has joined Shaw Dental Laboratory Inc. (“Shaw Group”), an Equicapita portfolio company, as Deal Partner, CEO and President. Equicapita’s Deal Partner program provides an opportunity for successful operating executives to co-own and lead our portfolio companies in alignment with Equicapita’s principals and investors. “We are excited to partner with Ali on our first Eastern Canadian acquisition. His deep operational leadership experience and proven track record across multiple industries will enhance our value proposition to the existing Shaw Group management team and his meaningful personal equity investment in the business demonstrates his belief in our investment thesis,” said Adam Jezewski, Managing Director of Equicapita’s Eastern Canadian office. “We look forward to working with Ali and the rest of the Shaw Group team to continue the company’s growth and success for years to come”.
Ali has over 20 years of experience as an operations executive with several private-equity owned businesses and as an operating partner and advisor to leading mid-market private equity firms. Most recently, Ali was Vice President of Operations and Engineering of Gehl Foods, LLC, a leading North American manufacturer of aseptic dairy products and is an advisor to Founders Group of Food Companies, Inc, a family-owned company that invests its own capital and applies operating know-how. Prior to these roles, Ali was Vice President of Operations of Golden Boy Foods Inc., a subsidiary of Post Holdings, Inc. (NYSE:POST) and leading manufacturer, marketer and distributor of private label and branded nut and fruit products. During his career, Ali has held senior operational management roles with chemical, personal and home care and food and beverage manufacturing businesses throughout North America. Ali holds degrees in engineering and management.
Equicapita’s Deal Partner program aligns Equicapita’s long duration capital solution and operations-centric investment strategy with outstanding executives that are seeking to co-own and lead an established business in partnership with a long-term private equity investor.
Founded in 1944, Shaw Group is one of the leading networks of dental laboratories in Ontario, with locations in Toronto, London, Ottawa, Kingston and Brampton as well as U.S. laboratories in Pennsylvania and Illinois. Shaw Group, whose diverse customer base includes over 1,500 dentists, has an established reputation for technical leadership and outstanding customer service.
Founded in 2013, Equicapita is a private company buyout fund with offices in Calgary, Alberta and Burlington, Ontario with over $180 million in AUM focused on acquiring private, Canadian businesses with enterprise values ranging from $5 million to $50+ million.
For more information please contact:
Adam Jezewski, Managing Director, Eastern Canada
This news release may contain certain information that is forward-looking, and, by its nature, such forward-looking information is subject to important risks and uncertainties. The words “anticipate,” “expect,” “may,” “should”,” “project,”, “will” or other similar words are used to identify such forward-looking information. Those forward-looking statements herein made reflect Equicapita’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those anticipated or predicted in these forward-looking statements, and the differences may be material. Factors which could cause actual results or events to differ materially from current expectations include, among other things: risks associated with the ownership and operation of businesses, including fluctuations in interest rates; employment retention; general economic conditions; supply and demand for businesses; competition for available businesses; changes in legislation and the regulatory environment; and international trade and global political conditions. Readers are cautioned not to place undue reliance on any forward-looking information contained in this news release. The forward-looking statements contained in this press release are made as of the date hereof and Equicapita undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.